Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedinotecMDNC 24 Earnings Yield (Joel Greenblatt) % is 1.91% as of May. 2026, which is at its 10-year median of 1.91. GuruFocus rates MDNC with a GF Score™ of 24/100. The stock has 1 warning sign investors should review.
Medinotec's Enterprise Value for the quarter that ended in May. 2026 was $56.27 Mil.
Medinotec's EBIT for the trailing twelve months (TTM) ended in May. 2026 was $1.08 Mil. Medinotec's Earnings Yield (Joel Greenblatt) for the quarter that ended in May. 2026 was 1.91%.
The historical rank and industry rank for Medinotec's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
MDNC'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -0.4 Med: 1.91 Max: 6.03
Current: 1.89
During the past 5 years, the highest Earnings Yield (Joel Greenblatt) of Medinotec was 6.03%. The lowest was -0.40%. And the median was 1.91%.
MDNC's Earnings Yield (Joel Greenblatt) % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 1.13
vs MDNC: 1.89
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Medinotec's Forward Rate of Return (Yacktman) % for the quarter that ended in May. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Medinotec Earnings Yield (Joel Greenblatt) % Related Terms
Medinotec Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Medinotec's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medinotec's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medinotec Earnings Yield (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medinotec's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Medinotec's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Medinotecs Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Feb. 2026 is calculated as
Medinotec's EBIT for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.08 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 1.91% mean?
Medinotec (MDNC) has a Earnings Yield (Joel Greenblatt) % of 1.91% as of May. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Medinotec and its competitors. This is near median its historical median of 1.91.
Is Medinotec's Earnings Yield (Joel Greenblatt) % too high?
Medinotec's current Earnings Yield (Joel Greenblatt) % of 1.91% is near median its 10-year median of 1.91. The Medical Devices & Instruments industry median Earnings Yield (Joel Greenblatt) % is 1.13. Medinotec's value of 1.91% is 69% above this industry median. Overall, Medinotec has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Medinotec's Earnings Yield (Joel Greenblatt) % compare to NVNO and APYX?
Medinotec's Earnings Yield (Joel Greenblatt) % of 1.91% can be compared against companies in the Medical Devices & Instruments industry. The industry median Earnings Yield (Joel Greenblatt) % is 1.13. Medinotec's value of 1.91% is 69% above this benchmark. While the company's 10-year median is 1.91 vs. the industry median of 1.13, Medinotec has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median Earnings Yield (Joel Greenblatt) % among Medical Devices & Instruments companies is 1.13, based on 847 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medinotec's current Earnings Yield (Joel Greenblatt) % of 1.91% is 69% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Medinotec and its competitors. For the Medical Devices & Instruments industry, the median Earnings Yield (Joel Greenblatt) % is 1.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medinotec's current Earnings Yield (Joel Greenblatt) % is 1.91%, which is near median its own 10-year median of 1.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinotec stock overvalued right now?
Medinotec (MDNC) has a current Earnings Yield (Joel Greenblatt) % of 1.91%. The current Earnings Yield (Joel Greenblatt) % is 1.91%, which is near median its 10-year median of 1.91 and 69% above the Medical Devices & Instruments industry median of 1.13. Medinotec's overall GF Score™ is 24/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Medinotec (MDNC), the current Earnings Yield (Joel Greenblatt) % is 1.91% as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medinotec Inc is a medical device manufacturing and distribution company engaged in tracheal non-occlusive airway dilation technology and medical device design. It generates revenue from two sources: internally designed and manufactured medical devices and distribution of third-party medical products under exclusive or non-exclusive agreements in defined territories. Its products include the Trachealator, the Outflo Aortic Valve Dilation Balloon Catheter, and the Cape Cross family of PTCA balloon catheters. It also distributes a range of cardiology and renal dialysis products on behalf of multinational manufacturers, mainly in South Africa. Its segments are Inside the United States and Outside the United States, with Outside the United States generating maximum revenue.
24GF Score
Get the complete analysis for MDNC
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDNC has been successfully added to your 
